{"id":1243809,"title":"DSEN Abstract: Hepatitis C Virus Treatment: Contribution of Patient Genetics in Ribavirin-induced Anemia - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-04-02","captureTimestamp":"2026-04-02T23:19:39.082000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/52727.html","snippet":"DSEN Abstract Hepatitis C Virus Treatment: Contribution of Patient Genetics in Ribavirin-induced Anemia In the treatment of chronic hepatitis C, ribavirin is often incorporated to improve treatment effectiveness. However, 1 in 3 treated patients develop severe anemia. This study…","rawSnapshotUrl":"/api/snapshots/raw/1243809","browseUrl":"https://replay.healtharchive.ca/job-8/20260402231939/https://cihr-irsc.gc.ca/e/52727.html#ha_snapshot=1243809","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}